

| Organism | Homo sapiens, human |
|---|---|
| Tissue | cecum |
| Product Format | frozen |
| Morphology | epithelial |
| Culture Properties | floating aggregates of round cells with some attached cells |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease | colorectal adenocarcinoma |
| Age | 55 years |
| Gender | male |
| Ethnicity | Caucasian |
| Karyotype | modal number = 102; range = 71 to 131; most cells have DM''''s |
|---|---|
| Derivation |
This line was derived from a metastasis to the abdominal wall obtained from a patient after treatment with 5-fluorouracil.
|
| Clinical Data |
55 years
Caucasian
male
|
| Antigen Expression |
Blood type A; Rh+; CA19-9 antigen
|
| Genes Expressed |
carcinoembryonic antigen (CEA), 1709 ng/mL per 106 cells per 10 days
|
| Cellular Products |
carcinoembryonic antigen (CEA), 1709 ng/mL per 106 cells per 10 days
|
| Tumorigenic | Yes |
| Effects |
Yes, in nude mice Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells
|
| Comments |
The cells contain Dopa decarboxylase, CA19-9 antigen and CEA but do not express the TAG-72 antigen. |
| Complete Growth Medium |
The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. |
|---|---|
| Subculturing |
Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended Medium Renewal: 3 times per week |
| Cryopreservation |
Culture medium, 95%; DMSO, 5%
|


